NYU Langone Health

FOR US AUDIENCES ONLY

NYU Langone Health

The ExEm® Foam Inc. team was excited to meet with the renowned Dr. Steven R. Goldstein, M.D. this past week at NYU Langone Health, one of the nation’s premier academic medical centers located in the heart of Manhattan.

The goal of the visit was to introduce a new technology in tubal patency testing for women with known or suspected infertility. The innovative imaging technique offers a less complicated and less invasive alternative to laparoscopy and dye, the gold standard for diagnosing tubal patency. The outpatient tubal assessment is also associated with significantly lower pain scores as compared to the standard of care, X-ray hysterosalpingography (HSG), and does not require the use of radiation and iodine.

ExEm® Foam Inc. continues to visit and train healthcare professionals in facilities across the US. Contact us for more information if you are interested in using ExEm® Foam ((air polymer-type A) intrauterine foam) for your patients.

lwolfe632021-09-01T22:38:51+00:00

ExEm® Foam is an innovative, FDA-approved product that offers a less invasive and effective alternative to other tubal patency assessment procedures, like laparoscopy or X-Ray HSG.

ExEm^® Foam Inc. is an affiliate of IQ MEDICAL VENTURES, B.V. ExEm^® is a registered trademark of GISKIT PHARMA B.V.

Important Safety Information: ExEm^® Foam should not be used on patients who are pregnant, have known or suspected lower genital tract inflammation or infection, have had a gynecologic procedure within the last 30 days, have vaginal bleeding, or have known or suspected reproductive tract neoplasia. Common side effects include pelvic and abdominal pain, vasovagal reactions (and associated symptoms such as nausea and faintness), and post-procedure spotting. Click here for full prescribing information.

References:

‍1. Ludwin I., Ludwin, A. et al. Accuracy of hysterosalpingo-foam sonography in comparison to hysterosalpingo-contrast sonography with air/saline and to laparoscopy with dye. Human Reproduction 2017, 32(4):758–69
‍
‍2. Riganelli L., Casorelli A. et al. Ultrasonography reappraisal of tubal patency in assisted reproduction technology patients: comparison between 2D and3D-sonohysterosalpingography. A pilot study. Minerva Ginecologica 2018, 70(2):123-28
‍
3. Dreyer, K., Out, R. et al. Hysterosalpingo-foam sonography, a less painful procedure for tubal patency testing during fertility workup compared with (serial) hysterosalpingography: A randomized controlled trial. Fertility and Sterility 2014, 102(3):821-25

ExEm_US_02_v27

ExEm^® Foam Inc. is an affiliate of IQ MEDICAL VENTURES, B.V. ExEm^® is a registered trademark of GISKIT PHARMA B.V.